Hydrocortisone cream ( DrugBank: Hydrocortisone )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-000657-36-NL (EUCTR)	22/06/2015	03/06/2015	Trial to investigate the efficacy of treatments in apomorphine-induced skin reactions	Open-label crossover trial to investigate the efficacy of treatments in apomorphine-induced skin reactions - Treatment of apomorphine-induced skin reactions: a pilot study	Parkinson's disease;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: Hydrocortisone cream 10mg/g FNA Fagron Product Name: Hydrocortisone cream Trade Name: Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial' Product Name: Solu-Cortef Trade Name: APO-go Product Name: Apomorphine	University Medical Center Groningen	NULL	Not Recruiting			Female: yes Male: yes	20	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no	Netherlands
2	NCT02230930 (ClinicalTrials.gov)	June 2015	29/8/2014	Treatment of Apomorphine-induced Skin Reactions: a Pilot Study	Open-label Crossover Trial to Investigate the Efficacy of Treatments in Apomorphine-induced Skin Reactions	Parkinson's Disease;Apomorphine-induced Skin Reactions	Drug: Apomorphine 0.25% (2.5mg/ml);Device: Massage with a spiky ball;Drug: Hydrocortisone cream 1%;Drug: Subcutaneous hydrocortisone 10mg	University Medical Center Groningen	NULL	Recruiting	30 Years	N/A	All	20	Phase 2	Netherlands